Medicine Grand Rounds: Overcoming Therapeutic Resistance of HER2-Positive Breast Cancer Presented by Elena Shagisultanova, MD, PhD, Associate Professor, Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus. 

Join us in person! Bruce Schroffel Auditorium, University of Colorado Hospital, Anschutz Inpatient Pavilion 2, First Floor Conference Room – Lunch Provided
or via Zoom.

Learning Objectives

• Recognize molecular drivers of breast cancer
• Understand the role of HER2 oncogene and HER2-targeted therapy in breast cancer
• Identify major pathways of resistance to HER2-targeted therapy, and strategies to overcome drug resistance. 

Accreditation & Designation Statement: The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Colorado School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit information to ACGME for the purpose of granting ABIM MOC credit.

Disclosure Statement: Dr. Shagisultanova reports a relevant financial relationship as a consultant for Pfizer inc., Novartis, Cogent Bioscience, Takara, and Genentech. All the relevant financial relationships listed for these individuals have been mitigated. All the other planners, faculty or individuals in control of content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies, whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.